Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abluferon, abundantly, abusive, accrual, acquiror, adjuvant, aid, albumin, Amgen, analog, anchor, API, attrition, awaiting, bavituximab, besudotox, Biogen, bringing, buy, bypassing, carefully, carmustine, cavity, chemo, cintredekin, coercive, commerical, comparison, concurrent, convenience, cumulative, depression, diphtheria, Discourage, dissimilar, diverse, diversity, dividend, drawn, ease, eighteen, Eli, enzastuarin, Error, fast, foregoing, frustrate, gave, gene, genotype, Gliadel, healthcare, hematologic, Herceptin, histone, Ia, Ib, ideally, Idec, Idenix, Immunotherapeutic, implant, impracticable, incremental, Infergen, Ingredient, inhibitor, inserted, interferon, Lilly, Medarex, MGI, microenvironment, monotherapy, narrow, Notwithstanding, Ofthe, orally, payoff, Pharma, phosphatidylserine, pill, pipeline, poison, polifeprosan, polymerase, polynucleotide, prevalence, principle, prodrug, protease, PS, questioning, rata, recommend, recovery, redeem, reward, road, Squibb, strain, surgery, takeover, taribavirin, taxation, temazolomide, Temodar, tender, thirty, thousandth, threshold, toxin, track, uncommon, unsolicited, unvested, Viramidine, Wafer
Removed:
AACR, abundant, Alan, alive, American, amplification, amplified, area, artificial, artificially, ASCO, assigned, assignment, assumed, avalanche, bankruptcy, BCNU, blockage, bore, bought, Cambridge, cancellation, capillary, carcinoma, carried, cascade, CAT, clearance, clinically, clone, clotting, colon, colorectal, combine, concentrated, concept, confirm, contrary, deemed, destruction, detectable, devastating, divided, dosing, doxorubicin, environment, epitope, Epstein, exit, experimental, exposing, forgive, GLIOMA, harmful, huge, identification, individual, inducing, infusion, input, instability, intention, interpretation, invested, investigation, investigator, involving, jointly, killing, kit, label, leading, list, liver, living, localize, locally, location, lymphatic, marker, measure, median, mice, middle, migrate, minimal, modulate, murine, neighboring, network, nuclear, organism, overcome, overgrowth, owed, Oxigene, payload, petition, Philip, plate, porosity, potent, problem, progression, reaction, realizing, recurrence, representing, reputation, rescind, resistance, resistant, role, selective, shape, show, smallcap, Society, solution, speed, stable, stanford, stream, structural, successive, survival, Taxol, Thorpe, traditional, transferable, treating, tube, Tubelike, UNAUDITED, underlie, uniquely, unrealized, unregistered, unsecured, venture, vinblastine, virtually, vitro, VIVO, waiver
Filing tables
Filing exhibits
- 10-K Annual report
- 10.106 Form of Performance Share Award Agreement / Stock Bonus Plan Dated February 13, 2006 Between Registrant and Key Employees and Consultants
- 21 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
CDMO similar filings
Filing view
External links
EXHIBIT 21
PEREGRINE PHARMACEUTICALS, INC.
Subsidiaries of Registrant
During January 2002, the Company announced the formation of Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc.
On April 24, 1997, the Company acquired its wholly owned subsidiary, Vascular Targeting Technologies, Inc. (formerly known as Peregrine Pharmaceuticals,Inc.).